scispace - formally typeset
D

Dallas Hughes

Researcher at NovoBiotic Pharmaceuticals

Publications -  19
Citations -  2449

Dallas Hughes is an academic researcher from NovoBiotic Pharmaceuticals. The author has contributed to research in topics: Lipid II & Chemistry. The author has an hindex of 8, co-authored 16 publications receiving 2060 citations.

Papers
More filters
Journal ArticleDOI

A new antibiotic kills pathogens without detectable resistance

TL;DR: The properties of this compound suggest a path towards developing antibiotics that are likely to avoid development of resistance, as well as several methods to grow uncultured organisms by cultivation in situ or by using specific growth factors.
Journal ArticleDOI

Lassomycin, a Ribosomally Synthesized Cyclic Peptide, Kills Mycobacterium tuberculosis by Targeting the ATP-Dependent Protease ClpC1P1P2

TL;DR: It is shown that lassomycin binds to a highly acidic region of the ClpC1 ATPase complex and markedly stimulates its ATPase activity without stimulating ClpP1P2-catalyzed protein breakdown, which is essential for viability of mycobacteria.
Journal ArticleDOI

Erratum: A new antibiotic kills pathogens without detectable resistance

TL;DR: This corrects the article to show that the Higgs boson genome is a “spatially aggregated “vessel” rather than an “ aggregating “ nucleus”, which indicates that theorems related to “consolidation” and “ghosting” are more likely to occur.
Journal ArticleDOI

Affinity capillary electrophoresis for the screening of novel antimicrobial targets.

TL;DR: The authors employed affinity capillary electrophoresis (ACE) to identify antimicrobial compounds that bound the novel target YihA and validate ACE as a valuable tool for the fast, efficient detection of specific binding molecules that possess biological activity.